— Know what they know.
Not Investment Advice
Also trades as: GSK.L (LSE) · $vol 186M · GS7.DE (XETRA) · $vol 2M · GLAXF (OTC) · $vol 0M

GSK NYSE

GSK plc
1W: +3.3% 1M: +3.8% 3M: -4.9% YTD: +3.8% 1Y: +13.2% 3Y: +58.2% 5Y: +57.7%
$50.94
-0.16 (-0.31%)
After Hours: $50.75 (-0.19, -0.37%)
Weekly Expected Move ±3.6%
$47 $49 $51 $53 $54
NYSE · Healthcare · Drug Manufacturers - General · Tech Score Buy · Power 60 · $102.4B mcap · 1.94B float · 0.211% daily turnover · Short 38% of daily vol
Credit Risk of going bust: lower than 77% of companies Debt: 19.1% of company value Bonds: $161.7M held by 148 funds, 43 bp over Treasuries → details ▾
If the stock fell to about $0.84 (down 98%), GSK plc would be worth roughly what it owes.
Total debt $24.20B against a stock market value of $102.38B.
Distance to default 9.00 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $14.94B (short-term plus half of long-term), stock volatility 26.2%; Altman Z'' 1.49. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

📊 Key Metrics

TTM
$33B
Revenue
+5.0% YoY
$5B
Net Income
+40.8% YoY
$7B
Free Cash Flow
+49.6% YoY
73.1%
Gross Margin
5.7%
Op. Margin
5.2%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE25.5%
ROA6.8%
ROIC18.8%

Valuation

P/E16.0
P/B4.4
EV/EBITDA0.0

Leverage

Debt/Equity1.03
Current Ratio0.82
Interest Cov.9.6x

Quality Scores

Piotroski F7/9
Altman Z—
Beneish M-3.08

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms